Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Leukaemia, Myelodysplastic syndrome (MDS)
Closed
Phase 1
This study is looking at a new drug called KHK2823 as a treatment for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS).
Recruitment start: 1 August 2014
Recruitment end: 30 June 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Deborah Richardson
Experimental Cancer Medicine Centre (ECMC)
Kyowa Hakka Kirin Pharma Inc
Last reviewed: 16 Jul 2017
CRUK internal database number: 12798
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
